An algorithmic and cost-effective testing method
Our coagulation-focused algorithms were developed collaboratively among physicians, pathologists, laboratorians, and genetic counselors. These algorithms recommend approaches for diagnosis of specific diseases and assist in treatment and monitoring of patient care. In addition, they guide proper and cost-effective test utilization (e.g., activated protein C resistance testing with reflex to factor V Leiden analysis).
The latest
Mayo Clinic researchers identify a new subtype of MGTS, linked to recurrent blood clots, with significant diagnostic challenges and treatment implications.
No posts available.